Form 4: Core Scientific Director Acquires 195,000 Shares and Warrants

Core Scientific director Yadin Rozov acquired 195,000 shares of common stock and 195,000 Tranche 2 warrants at a price of $0.01 per share.

Summary

• On November 11, 2024, Yadin Rozov, a director at Core Scientific, Inc., acquired 195,000 shares of common stock at a price of $0.01 per share.
• Rozov also acquired 195,000 Tranche 2 warrants, each exercisable for one share of common stock at $0.01 per share, contingent on the stock price reaching $8.72 for 20 consecutive trading days.
• The Tranche 2 warrants became exercisable on July 11, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is a positive sign, but the warrants are contingent on future stock performance.

Positives

• The acquisition of shares by a director could be seen as a positive sign of confidence in the company's future.

Risks

• The exercise of the warrants is contingent on the stock price reaching $8.72 for 20 consecutive trading days, which may not occur.

Future Outlook

The future exercise of the warrants depends on the company's stock price performance.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's stock.

Comparison to Industry Standards

• Form 4 filings are a standard practice for all publicly traded companies in the US, and this filing is consistent with those standards.
• The acquisition of shares and warrants by a director is a common occurrence and is not unusual in the context of corporate governance.

Stakeholder Impact

• The acquisition of shares by a director may be viewed positively by shareholders.

Key Dates

Keywords

Core Scientific, CORZ, Yadin Rozov, stock acquisition, warrants, insider trading, Form 4, director